Hemostatic Activity of Chitosan in Wound Management

Abstract

Research has been initiated on the preparation of a hemostatic agent which contains chitosan glutamate. A source for chitosan glutamate raw material has been located and characterization of the material is underway. A source for the collagen portion of the composite hemostatic sponge has also been identified and prototype sponges are currently being produced both by 3M and an outside vendor. The preclinical testing plan has been reviewed with the FDA, and it appears at this stage that the testing plan, as proposed, is an appropriate starting point. Keywords: Collagen; Chitosan glutamate; Hemostatic agents.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Mar 27, 1989
Accession Number
ADA211370

Entities

People

  • Terry W. Lewis

Organizations

  • 3M

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Acetic Acid
  • Amino Acids
  • Classification
  • Collagen
  • Contracts
  • Elements
  • Gel Electrophoresis
  • Glutamates
  • Heavy Metals
  • Materials
  • Military Research
  • Molecular Weight
  • Monitoring
  • New York
  • Polysaccharides
  • Security
  • Test And Evaluation

Readers

  • Molecular and Cellular Biochemistry
  • Software Engineering
  • Trauma Surgery or Emergency Medicine.